RU2001103131A - URATOXIDASE - Google Patents
URATOXIDASEInfo
- Publication number
- RU2001103131A RU2001103131A RU2001103131/13A RU2001103131A RU2001103131A RU 2001103131 A RU2001103131 A RU 2001103131A RU 2001103131/13 A RU2001103131/13 A RU 2001103131/13A RU 2001103131 A RU2001103131 A RU 2001103131A RU 2001103131 A RU2001103131 A RU 2001103131A
- Authority
- RU
- Russia
- Prior art keywords
- uricase
- amino acids
- protein
- nucleic acid
- acid molecule
- Prior art date
Links
- 108010092464 Urate Oxidase Proteins 0.000 claims 16
- 150000001413 amino acids Chemical class 0.000 claims 13
- 108020004707 nucleic acids Proteins 0.000 claims 8
- 150000007523 nucleic acids Chemical class 0.000 claims 8
- 108090000623 proteins and genes Proteins 0.000 claims 4
- 102000004169 proteins and genes Human genes 0.000 claims 4
- 108020001507 fusion proteins Proteins 0.000 claims 3
- 102000037240 fusion proteins Human genes 0.000 claims 3
- 125000003588 lysine group Chemical group [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 claims 3
- 229920001850 Nucleic acid sequence Polymers 0.000 claims 2
- 241001504519 Papio ursinus Species 0.000 claims 2
- 241000282898 Sus scrofa Species 0.000 claims 2
- 229920001223 polyethylene glycol Polymers 0.000 claims 2
- 239000004475 Arginine Substances 0.000 claims 1
- 102000007312 Recombinant Proteins Human genes 0.000 claims 1
- 108010033725 Recombinant Proteins Proteins 0.000 claims 1
- 125000003275 alpha amino acid group Chemical group 0.000 claims 1
- 238000010348 incorporation Methods 0.000 claims 1
- 241000894007 species Species 0.000 claims 1
Claims (17)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US9548998P | 1998-08-06 | 1998-08-06 | |
US60/095,489 | 1998-08-06 |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2001103131A true RU2001103131A (en) | 2003-04-10 |
RU2290439C2 RU2290439C2 (en) | 2006-12-27 |
Family
ID=22252247
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2001103131/13A RU2290439C2 (en) | 1998-08-06 | 1999-08-05 | Recombinant mammalian uricase protein for conjunction with peg, nucleic acid molecule encoding the same expression vector, methods for production abd uses thereof |
Country Status (23)
Country | Link |
---|---|
US (1) | US7056713B1 (en) |
EP (2) | EP2277998B1 (en) |
JP (3) | JP2002524053A (en) |
KR (1) | KR100841634B1 (en) |
CN (2) | CN1322243A (en) |
AT (1) | ATE483797T1 (en) |
AU (1) | AU766421B2 (en) |
BR (1) | BRPI9913360B8 (en) |
CA (1) | CA2337967C (en) |
CY (1) | CY1111001T1 (en) |
CZ (1) | CZ304223B6 (en) |
DE (1) | DE69942834D1 (en) |
DK (1) | DK1100880T3 (en) |
ES (1) | ES2352451T3 (en) |
HK (3) | HK1037214A1 (en) |
HU (1) | HU229774B1 (en) |
IL (3) | IL141221A0 (en) |
NZ (1) | NZ509633A (en) |
PL (1) | PL207369B1 (en) |
PT (1) | PT1100880E (en) |
RU (1) | RU2290439C2 (en) |
WO (1) | WO2000008196A2 (en) |
ZA (1) | ZA200100974B (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2451074C2 (en) * | 2005-04-11 | 2012-05-20 | Савиент Фармасьютикалз, Инк. | Alternative forms of urate oxidase and using them |
US10139399B2 (en) | 2009-06-25 | 2018-11-27 | Horizon Pharma Rheumatology Llc | Methods and kits for predicting infusion reaction risk and antibody-mediated loss of response by monitoring serum uric acid during PEGylated uricase therapy |
Families Citing this family (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT2158923E (en) | 1998-08-06 | 2013-06-04 | Univ Duke | Peg-urate oxidase conjugates and use thereof |
US6783965B1 (en) | 2000-02-10 | 2004-08-31 | Mountain View Pharmaceuticals, Inc. | Aggregate-free urate oxidase for preparation of non-immunogenic polymer conjugates |
RU2246318C2 (en) * | 1998-08-06 | 2005-02-20 | Маунтэн Вью Фармасьютикэлз, Инк. | Uricase peg-conjugates and their applying |
US20060188971A1 (en) * | 1998-08-06 | 2006-08-24 | Duke University | Urate oxidase |
PL207369B1 (en) * | 1998-08-06 | 2010-12-31 | Univ Duke | Urate oxidase |
CN100371439C (en) * | 2003-04-07 | 2008-02-27 | 北京双鹭药业股份有限公司 | Preparation method of recombinant can diad urate oxidase |
CN100334207C (en) * | 2004-04-27 | 2007-08-29 | 杭州北斗生物技术有限公司 | Process for preparing aspergillus flavus urate oxidase |
BRPI0612942A2 (en) * | 2005-04-11 | 2012-10-09 | Savient Pharmaceuticals Inc | variant form of urate oxidase and its use |
US8148123B2 (en) | 2005-04-11 | 2012-04-03 | Savient Pharmaceuticals, Inc. | Methods for lowering elevated uric acid levels using intravenous injections of PEG-uricase |
AU2011257764B2 (en) * | 2005-04-11 | 2012-04-05 | Horizon Therapeutics Usa, Inc. | A variant form of urate oxidase and use thereof |
PL2013225T3 (en) * | 2006-04-12 | 2015-06-30 | Crealta Pharmaceuticals Llc | Purification of proteins with cationic surfactant |
CN101402688B (en) * | 2008-11-18 | 2011-04-20 | 中国人民解放军军事医学科学院生物工程研究所 | Fusion protein, encoding gene and uses thereof |
AU2010229341B9 (en) | 2009-03-24 | 2013-06-27 | Meito Sangyo Co., Ltd. | Improved type milk-clotting protease derived from a microorganism |
CN102051348B (en) * | 2009-10-27 | 2012-10-03 | 重庆富进生物医药有限公司 | Humanized recombinant uricase and mutant thereof |
RU2460793C2 (en) | 2010-01-15 | 2012-09-10 | Закрытое акционерное общество "Научно-исследовательский институт "Аджиномото-Генетика" (ЗАО АГРИ) | Method for producing l-amino acids with use of bacteria of enterobacteriaceae family |
US8940861B2 (en) | 2010-04-08 | 2015-01-27 | Georgia Tech Research Corporation | Variants of ancestral uricases and uses thereof |
CN102634492B (en) * | 2011-02-14 | 2015-06-10 | 重庆富进生物医药有限公司 | Polyethylene glycol dog source urate oxidase analogue, and preparation method and applications thereof |
CN102757945B (en) * | 2011-04-28 | 2015-03-18 | 杭州俊丰生物工程有限公司 | Human urate oxidase protein and preparation method and polyethylene glycol composite thereof |
CN102260653B (en) * | 2011-06-30 | 2013-04-03 | 荣俊 | Preparation and application method of PEG recombinant pig-human urate oxidase fusion protein |
EP2986720B1 (en) * | 2013-04-17 | 2017-09-06 | Council of Scientific & Industrial Research | Uricase mutants |
CN103834623B (en) * | 2014-02-11 | 2017-11-07 | 中国药科大学 | People source urate oxidase with catalytic activity |
CN104388467A (en) * | 2014-10-27 | 2015-03-04 | 李长贵 | Method for constructing spontaneous hyperuricemia mouse model and application of mouse model |
CN107614007B (en) | 2015-05-15 | 2022-03-25 | 免疫医疗有限责任公司 | Improved uricase sequences and methods of treatment |
CN106554948B (en) * | 2015-09-29 | 2019-06-25 | 上海生物制品研究所有限责任公司 | Saltant type uricase, the saltant type uricase of PEG modification and its application |
CN108103079B (en) * | 2017-06-20 | 2021-07-13 | 北京锦篮基因科技有限公司 | Gene therapy medicine for hyperuricemia |
CN109554376B (en) * | 2018-11-13 | 2022-03-22 | 广西大学 | Alkaline urate oxidase and application thereof in detection kit and reduction of uric acid in food |
CN111088268B (en) * | 2019-03-05 | 2022-08-02 | 北京锦篮基因科技有限公司 | Gene therapy medicine for hyperuricemia |
AU2020276510A1 (en) | 2019-05-10 | 2021-12-16 | Hangzhou Grand Biologic Pharmaceutical Inc. | Polyethylene glycol-modified urate oxidase |
CN112646790A (en) * | 2019-10-11 | 2021-04-13 | 上海君实生物医药科技股份有限公司 | Improved uricase and methods for its use in treating hyperuricemia |
CN111920942A (en) * | 2020-08-24 | 2020-11-13 | 深圳前海鹰岗生物科技有限公司 | Polymer microneedle for rapidly dissolving tophus and preparation method and application |
CN114438048A (en) | 2020-11-05 | 2022-05-06 | 重庆派金生物科技有限公司 | Urate oxidase preparation and application thereof |
CN114438047A (en) | 2020-11-05 | 2022-05-06 | 重庆派金生物科技有限公司 | Method for preparing polyethylene glycol modified urate oxidase |
CN112852772A (en) * | 2021-01-19 | 2021-05-28 | 中国科学院过程工程研究所 | Urate oxidase based on intramolecular cross-linking and polyethylene glycol modification and preparation method thereof |
CN112662640A (en) * | 2021-01-28 | 2021-04-16 | 中国药科大学 | Urate oxidase with catalytic activity |
CN113244412B (en) * | 2021-06-25 | 2021-10-26 | 深圳市瑞吉生物科技有限公司 | Medicine for treating hyperuricemia or gout based on mRNA dosage form and preparation method thereof |
AU2022340814A1 (en) * | 2021-09-01 | 2024-02-15 | Ginkgo Bioworks, Inc. | Recombinant cells for treating diseases associated with uric acid and methods of use thereof |
Family Cites Families (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE279486C (en) | ||||
US3613231A (en) | 1969-07-25 | 1971-10-19 | Paul F Pugh | Method for manufacturing high voltage cable systems |
US4179337A (en) | 1973-07-20 | 1979-12-18 | Davis Frank F | Non-immunogenic polypeptides |
DE3126759A1 (en) | 1981-07-07 | 1983-01-27 | Boehringer Mannheim Gmbh, 6800 Mannheim | SOLUBLE LIVER URICASE, METHOD FOR THE PRODUCTION AND USE THEREOF |
US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
US4965188A (en) | 1986-08-22 | 1990-10-23 | Cetus Corporation | Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme |
US4917888A (en) * | 1985-06-26 | 1990-04-17 | Cetus Corporation | Solubilization of immunotoxins for pharmaceutical compositions using polymer conjugation |
US4766106A (en) | 1985-06-26 | 1988-08-23 | Cetus Corporation | Solubilization of proteins for pharmaceutical compositions using polymer conjugation |
US4847325A (en) | 1988-01-20 | 1989-07-11 | Cetus Corporation | Conjugation of polymer to colony stimulating factor-1 |
US5075216A (en) | 1988-09-23 | 1991-12-24 | Cetus Corporation | Methods for dna sequencing with thermus aquaticus dna polymerase |
US5349052A (en) | 1988-10-20 | 1994-09-20 | Royal Free Hospital School Of Medicine | Process for fractionating polyethylene glycol (PEG)-protein adducts and an adduct for PEG and granulocyte-macrophage colony stimulating factor |
US5324844A (en) | 1989-04-19 | 1994-06-28 | Enzon, Inc. | Active carbonates of polyalkylene oxides for modification of polypeptides |
US5382518A (en) | 1989-07-13 | 1995-01-17 | Sanofi | Urate oxidase activity protein, recombinant gene coding therefor, expression vector, micro-organisms and transformed cells |
US5286637A (en) | 1989-08-07 | 1994-02-15 | Debiopharm, S.A. | Biologically active drug polymer derivatives and method for preparing same |
US5653974A (en) | 1990-10-18 | 1997-08-05 | Board Of Regents,The University Of Texas System | Preparation and characterization of liposomal formulations of tumor necrosis factor |
WO1994019007A1 (en) | 1993-02-16 | 1994-09-01 | Enzon, Inc. | Ribosome inactivating protein compositions having reduced antigenicity |
WO1995000162A1 (en) | 1993-06-21 | 1995-01-05 | Enzon, Inc. | Site specific synthesis of conjugated peptides |
US5643575A (en) | 1993-10-27 | 1997-07-01 | Enzon, Inc. | Non-antigenic branched polymer conjugates |
US5919455A (en) | 1993-10-27 | 1999-07-06 | Enzon, Inc. | Non-antigenic branched polymer conjugates |
JPH10510516A (en) | 1994-12-07 | 1998-10-13 | ノボ ノルディスク アクティーゼルスカブ | Polypeptides with reduced allergenicity |
JPH09154581A (en) | 1995-12-05 | 1997-06-17 | Asahi Chem Ind Co Ltd | Substantially pure microorganism capable of producing uricase |
CA2279986A1 (en) | 1997-02-06 | 1998-08-13 | Novo Nordisk A/S | Polypeptide-polymer conjugates having added and/or removed attachment groups |
US6783965B1 (en) | 2000-02-10 | 2004-08-31 | Mountain View Pharmaceuticals, Inc. | Aggregate-free urate oxidase for preparation of non-immunogenic polymer conjugates |
RU2246318C2 (en) | 1998-08-06 | 2005-02-20 | Маунтэн Вью Фармасьютикэлз, Инк. | Uricase peg-conjugates and their applying |
PL207369B1 (en) * | 1998-08-06 | 2010-12-31 | Univ Duke | Urate oxidase |
PT2158923E (en) | 1998-08-06 | 2013-06-04 | Univ Duke | Peg-urate oxidase conjugates and use thereof |
-
1999
- 1999-08-05 PL PL346222A patent/PL207369B1/en unknown
- 1999-08-05 WO PCT/US1999/017678 patent/WO2000008196A2/en active IP Right Grant
- 1999-08-05 ES ES99938996T patent/ES2352451T3/en not_active Expired - Lifetime
- 1999-08-05 EP EP10007912.8A patent/EP2277998B1/en not_active Expired - Lifetime
- 1999-08-05 DE DE69942834T patent/DE69942834D1/en not_active Expired - Lifetime
- 1999-08-05 JP JP2000563819A patent/JP2002524053A/en active Pending
- 1999-08-05 US US09/762,097 patent/US7056713B1/en not_active Expired - Lifetime
- 1999-08-05 IL IL14122199A patent/IL141221A0/en unknown
- 1999-08-05 EP EP99938996A patent/EP1100880B1/en not_active Expired - Lifetime
- 1999-08-05 DK DK99938996.8T patent/DK1100880T3/en active
- 1999-08-05 PT PT99938996T patent/PT1100880E/en unknown
- 1999-08-05 KR KR1020017001618A patent/KR100841634B1/en active IP Right Grant
- 1999-08-05 RU RU2001103131/13A patent/RU2290439C2/en not_active IP Right Cessation
- 1999-08-05 CZ CZ2001-466A patent/CZ304223B6/en not_active IP Right Cessation
- 1999-08-05 CN CN99811738A patent/CN1322243A/en active Pending
- 1999-08-05 HU HU0103205A patent/HU229774B1/en not_active IP Right Cessation
- 1999-08-05 AU AU53365/99A patent/AU766421B2/en not_active Ceased
- 1999-08-05 AT AT99938996T patent/ATE483797T1/en active
- 1999-08-05 NZ NZ509633A patent/NZ509633A/en not_active IP Right Cessation
- 1999-08-05 CN CN2008100866511A patent/CN101280293B/en not_active Expired - Fee Related
- 1999-08-05 BR BRPI9913360A patent/BRPI9913360B8/en not_active IP Right Cessation
- 1999-08-05 CA CA2337967A patent/CA2337967C/en not_active Expired - Fee Related
-
2001
- 2001-02-01 IL IL141221A patent/IL141221A/en not_active IP Right Cessation
- 2001-02-05 ZA ZA2001/00974A patent/ZA200100974B/en unknown
- 2001-11-15 HK HK01108032.2A patent/HK1037214A1/en not_active IP Right Cessation
-
2009
- 2009-03-02 IL IL197339A patent/IL197339A/en not_active IP Right Cessation
- 2009-04-02 HK HK09103159.2A patent/HK1125402A1/en not_active IP Right Cessation
-
2010
- 2010-02-02 JP JP2010021520A patent/JP5721954B2/en not_active Expired - Fee Related
- 2010-12-21 CY CY20101101175T patent/CY1111001T1/en unknown
-
2011
- 2011-07-22 HK HK11107610.2A patent/HK1153508A1/en not_active IP Right Cessation
-
2013
- 2013-06-05 JP JP2013118803A patent/JP2013215199A/en active Pending
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2451074C2 (en) * | 2005-04-11 | 2012-05-20 | Савиент Фармасьютикалз, Инк. | Alternative forms of urate oxidase and using them |
RU2610680C2 (en) * | 2005-04-11 | 2017-02-14 | Криэлта Фармасьютикалз ЭлЭлСи | Variant forms of urate oxidase and use thereof |
RU2610680C9 (en) * | 2005-04-11 | 2018-05-30 | Криэлта Фармасьютикалз ЭлЭлСи | Variant forms of urate oxidase and use thereof |
US10160958B2 (en) | 2005-04-11 | 2018-12-25 | Horizon Pharma Rheumatology Llc | Variant forms of urate oxidase and use thereof |
US10731139B2 (en) | 2005-04-11 | 2020-08-04 | Horizon Pharma Rheumatology Llc | Variant forms of urate oxidase and use thereof |
US11345899B2 (en) | 2005-04-11 | 2022-05-31 | Horizon Therapeutics Usa, Inc. | Variant forms of urate oxidase and use thereof |
US10139399B2 (en) | 2009-06-25 | 2018-11-27 | Horizon Pharma Rheumatology Llc | Methods and kits for predicting infusion reaction risk and antibody-mediated loss of response by monitoring serum uric acid during PEGylated uricase therapy |
US10823727B2 (en) | 2009-06-25 | 2020-11-03 | Horizon Pharma Rheumatology Llc | Methods and kits for predicting infusion reaction risk and antibody-mediated loss of response by monitoring serum uric acid during pegylated uricase therapy |
US11639927B2 (en) | 2009-06-25 | 2023-05-02 | Horizon Therapeutics Usa, Inc. | Methods and kits for predicting infusion reaction risk and antibody-mediated loss of response by monitoring serum uric acid during PEGylated uricase therapy |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2001103131A (en) | URATOXIDASE | |
CA2337967A1 (en) | Recombinant uricase protein | |
Sluka et al. | Importance of minor-groove contacts for the recognition of DNA by the binding domain of Hin recombinase | |
PL317722A1 (en) | Sequences of synthetic leader peptides | |
EP0305488A4 (en) | Mycobacterial recombinants and peptides | |
WO2004108938A3 (en) | Peptide ligands of dendritic cells for nucleic acid vector targeting | |
AU7891498A (en) | Flower organ-specific gene and its promoter sequence | |
KR100237126B1 (en) | Rapid synthesis and screening of peptide mimetics | |
RU2000103824A (en) | Adipocyte-Specific Protein Homologues | |
SE9402089D0 (en) | Recombinant allergen, fragments thereof, corresponding recombinant DNA molecules, vectors and hosts containing the DNA molecules, diagnostic and therapeutic uses of said allergens and fragments | |
US20120107870A1 (en) | Selective enzymatic amidation of c-terminal esters or acids of peptides | |
DE3485199D1 (en) | ||
AU629430B2 (en) | Bacterial collagenase gene | |
WO2002010384A1 (en) | Genes encoding proteins capable of regenerating luciferin, recombinant dna and process for producing protein capable of regenerating luciferin | |
WO2000017232A3 (en) | Regulatory protein from human keratinocytes | |
EP2167673B1 (en) | Process for the conversion of c-terminal peptide esters or acids to amides employing subtilisin in the presence of ammonium salts | |
Stasiak et al. | Peptides derived from α-hydroxymethylserine: Aspects of solid-phase synthesis | |
EP0959895A4 (en) | Peptides responsive to antibodies against a consensus peptide of the cs4-cfa/i family proteins | |
WO2002010383A1 (en) | Genes encoding proteins capable of regenerating luciferin, recombinant dna and process for producing protein capable of regenerating luciferin | |
Miura et al. | Synthesis of a Fragment (Pentapeptide) of E. Coli Acyl Carrier Protein Apoprotein | |
WO2002022632A3 (en) | Nucleotide sequences coding for the pknd gene | |
RU99127322A (en) | PROTEINS CONNECTING TO SUGAROSE | |
CA2419038A1 (en) | Nucleic acid and protein increasing expression levels under salt stress | |
Marczak et al. | Practical approach to enzymatic resolution of Fmoc-and Boc-protected amino acid racemates | |
DE60021707D1 (en) | BETA-PRIMEVEROSIDASE GEN |